Abdullah Esmeray

Dr. Abdullah Esmeray


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2023 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
YPYasar Pazir
Yasar Pazir
AEAbdullah Esmeray
Abdullah Esmeray
UCUfuk Caglar
Ufuk Caglar
AEAkif Erbin
Akif Erbin
FOFaruk Ozgor
Faruk Ozgor
FAFatih Akbulut
Fatih Akbulut



25 October 2023 in Yeni Üroloji Dergisi
Verified
Journal Article
Closed access
PDF file
MGMEHMET HAMZA GULTEKIN
MEHMET HAMZA GULTEKIN
UCUfuk Caglar
Ufuk Caglar
AEAbdullah Esmeray
Abdullah Esmeray
AEAkif Erbin
Akif Erbin
FYFatih Yanaral
Fatih Yanaral
FAFatih Akbulut
Fatih Akbulut
Objective: Some systemic inflammatory response-based biomarkers are promising for predicting prognosis of non-muscle-invasive bladder cancer (NMIBC) patients and can contribute to the risk classification without any significant cost. We aimed to evaluate the neutrophil-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) for the prediction of recurrence and progression risk in patients with NMIBC. Material and Methods: The study included a retrospective analysis of 211 patients who underwent transurethral resection of bladder (TURB) in a tertiary referral center between 2015 and 2019. The receiver operating characteristic (ROC) curve was used to determine the cut-off value. The Kaplan-Meier curves and the log-rank test were constructed to evaluate the recurrence-free and progression-free survival rates according to different levels of inflammatory markers. The multivariate regression analysis was undertaken to estimate the independent prognostic factors. Results: The optimal cut-off value of SII was found to be 568 in the ROC analysis. According to the multivariate analysis, the SII value, number of tumors at the time of initial TURB, and European Organization for Research and Treatment of Cancer (EORTC) recurrence classification were statistically significant parameters in predicting recurrence. While tumor size, NLR, and SII achieved statistically significant levels in the univariate analysis, they didn’t have significance in the multivariate analysis. Conclusion: The SII, number of tumors, and EORTC recurrence classification are prognostic parameters that can be used in the assessment of recurrence. However, inflammatory parameters do not have the same predictive ability in the prediction of the progression rate.

20 April 2026
Verified
Book Chapter
Closed access
AEAbdullah Esmeray
Abdullah Esmeray
MTMuhammed Emre Topçu
Muhammed Emre Topçu

30 September 2026 in Endouroloji Bulteni
Verified
Journal Article
Closed access
AİAbdurrahman İnkaya
Abdurrahman İnkaya
HGhasan samet Güngör
hasan samet Güngör
NŞNurullaah Mustafa Şişik
Nurullaah Mustafa Şişik
MTMuhammed Emre Topçu
Muhammed Emre Topçu
BÖBahadır Öksüz
Bahadır Öksüz
EKEyüp Veli Küçük
Eyüp Veli Küçük
Objective: Positive surgical margins remain clinically relevant after robot-assisted radical prostatectomy (RARP). Whether performing extended pelvic lymph node dissection (ePLND) before, rather than after, prostatectomy is associated with lower apical positive surgical margin (PSM) rates has not been evaluated with adjusted comparative data.Materials and Methods: We performed a retrospective cohort study of 250 consecutive patients who underwent primary RARP with ePLND at a single tertiary centre. Patients were classified by operative sequence as ePLND-first (n = 121) or prostatectomy-first (n = 129). The primary multivariable analyses were conducted in the full 250-patient cohort with nerve-sparing intent coded as a 3-level categorical variable; a pre-specified subgroup analysis was conducted in the 188 patients undergoing any form of nerve-sparing surgery. The primary endpoint was apical PSM. Because apical PSM events were sparse, the adjusted analysis used Firth penalised logistic regression.Results: Baseline characteristics were similar between groups. Apical PSM occurred in 6 of 121 patients (5.0%; 95% confidence interval [CI] 2.3% to 10.4%) in the ePLND-first group and 13 of 129 (10.1%; 95% CI 6.0% to 16.5%) in the prostatectomy-first group. In the primary multivariable analysis of the full 250-patient cohort, ePLND-first sequencing was associated with lower adjusted odds of apical PSM (adjusted OR 0.38; 95% CI 0.14 to 1.03; p = 0.056); in the pre-specified nerve-sparing subgroup (n = 188), the adjusted association was stronger (OR 0.19; 95% CI 0.04 to 0.97; p = 0.046; unadjusted 1.2% vs 8.8%, Fisher’s exact p = 0.023). Total operative time was shorter in the ePLND-first group (195.2 vs 202.9 min; p = 0.029). Lymph node yield and major complication rates were similar between groups.Conclusion: In this retrospective cohort, performing ePLND before prostatectomy was associated with directionally lower adjusted odds of apical PSM during RARP in the full 250-patient cohort, with a stronger association in the pre-specified nerve-sparing subgroup analysis. For men undergoing nerve-sparing RARP with planned ePLND, sequence may represent a practical operative strategy associated with lower apical margin risk without an evident perioperative penalty.